iShares Biotechnology ETF $IBB Shares Acquired by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 5.4% in the 1st quarter, HoldingsChannel reports. The firm owned 652,818 shares of the financial services provider’s stock after purchasing an additional 33,268 shares during the period. Janney Montgomery Scott LLC’s holdings in iShares Biotechnology ETF were worth $110,228,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Citigroup Inc. boosted its stake in shares of iShares Biotechnology ETF by 40.9% during the 4th quarter. Citigroup Inc. now owns 5,242,688 shares of the financial services provider’s stock worth $884,808,000 after purchasing an additional 1,521,992 shares during the last quarter. Morgan Stanley raised its position in shares of iShares Biotechnology ETF by 2.5% in the fourth quarter. Morgan Stanley now owns 3,204,126 shares of the financial services provider’s stock valued at $540,760,000 after buying an additional 76,978 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in shares of iShares Biotechnology ETF by 11.4% during the fourth quarter. BNP Paribas Financial Markets now owns 2,133,461 shares of the financial services provider’s stock valued at $360,064,000 after buying an additional 218,066 shares during the period. Raymond James Financial Inc. boosted its holdings in shares of iShares Biotechnology ETF by 286.2% during the fourth quarter. Raymond James Financial Inc. now owns 994,311 shares of the financial services provider’s stock worth $167,810,000 after purchasing an additional 736,881 shares during the last quarter. Finally, LPL Financial LLC increased its stake in iShares Biotechnology ETF by 145.9% in the fourth quarter. LPL Financial LLC now owns 992,799 shares of the financial services provider’s stock valued at $167,555,000 after purchasing an additional 589,033 shares during the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 2.0%

NASDAQ IBB opened at $187.38 on Friday. The business’s 50-day moving average price is $171.45 and its 200 day moving average price is $171.03. iShares Biotechnology ETF has a twelve month low of $125.70 and a twelve month high of $188.69.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. This represents a $0.10 annualized dividend and a dividend yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.